Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®

PHASE4CompletedINTERVENTIONAL
Enrollment

442

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Symbicort Turbuhaler (budesonide/formoterol) 320/9 μg

DRUG

Seretide Diskus (salmeterol/fluticasone) 50/500 μg

Trial Locations (59)

Unknown

Research Site, Monte Grande

Research Site, Quilmes

Research Site, San Miguel de Tucumán

Research Site, Ciudad Autonoma de Bs. As.

Research Site, Ciudad de Buenos Aires

Research Site, Concord

Research Site, Adelaide

Research Site, Daw Park

Research Site, Woodville South

Research Site, Melbourne

Research Site, Parkville

Research Site, Nedlands

Research Site, Jambes

Research Site, Malmedy

Research Site, Montigny-le-Tilleul

Research Site, Porto Alegre

Research Site, Juiz de Fora

Research Site, Recife

Research Site, Rio de Janeiro

Research Site, Porto Alegre

Research Site, Florianópolis

Research Site, Santo André

Research Site, São Paulo

Research Site, Rio de Janeiro

Research Site, Aalborg

Research Site, Hellerup

Research Site, Hvidovre

Research Site, København NV

Research Site, Odense C

Research Site, Rødovre Municipality

Research Site, Silkeborg

Research Site, Berlin

Research Site, Erfurt

Research Site, Leipzig

Research Site, Marburg

Research Site, Hyderabad

Research Site, Bangalore

Research Site, Jaipur

Research Site, Coimbatore

Research Site, Noida

Research Site, Manila

Research Site, Quezon City

Research Site, Dartford

Research Site, Hamilton

Research Site, Motherwell

Research Site, Cookstown

Research Site, Limavady

Research Site, Newtownabbey

Research Site, Barry

Research Site, Barry

Research Site, Bradford-on-Avon

Research Site, Airdrie

Research Site, Birmingham

Research Site, Blantyre

Research Site, Bolton

Research Site, Carrickfergus

Research Site, Chesterfield

Research Site, Coventry

Research Site, Hamilton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY